HOME > Investors > Press Releases
2017-08-25
Strides Toward New Approaches: Dawn of a New Era in DFU Treatment
2017-08-07
ViroMed Gene Therapy for Non-Healing Diabetic Foot Ulcers Starts Phase III Trial
2017-08-04
VM BioPharma began dosing of VM202 in Phase 3 for Non-Healing Diabetic Foot Ulcers
2017-07-31
ViroMed to strengthen its global presence with top experts
2017-07-10
2017.07(IR letter) BusinessUpdates
1 2 3 4 5 6 7 8 9 10